Stenting versus medical treatment alone for symptomatic intracranial artery stenosis: a preplanned pooled individual patient data analysis

医学 冲程(发动机) 狭窄 内科学 随机对照试验 血管成形术 经皮 高脂血症 外科 糖尿病 机械工程 工程类 内分泌学
作者
Tao Wang,Jichang Luo,Tianhua Li,Eyad Almallouhi,Peng Gao,Haozhi Gong,Xiao Zhang,Jie Wang,Taoyuan Lu,Yifan Yang,Renjie Yang,Zixuan Xing,Haibo Wang,Colin P. Derdeyn,Liqun Jiao
出处
期刊:Journal of NeuroInterventional Surgery [BMJ]
卷期号:: jnis-022189
标识
DOI:10.1136/jnis-2024-022189
摘要

Background Whether the safety and efficacy of percutaneous transluminal angioplasty and stenting (PTAS) is significantly different from that of medical treatment alone for symptomatic intracranial arterial stenosis (ICAS) is debatable. A study was undertaken to determine the safety and efficacy of both treatments for symptomatic ICAS. Methods This preplanned pooled individual patient data analysis included 400 participants treated with PTAS and 409 treated with medical treatment alone in two large multicenter randomized clinical trials (SAMMPRIS and CASSISS). Patients were treated with PTAS using a self-expanding stent or medical treatment alone. The primary outcome was stroke or death within 30 days, or ischemic stroke in the territory of the qualifying artery more than 30 days after enrollment. Results Individual data were obtained for 809 patients, 451 from SAMMPRIS and 358 from CASSISS. 400 participants were randomly assigned to the PTAS group and 409 to the medical group. The risk of the primary outcome was not significant between the PTAS and medical groups (17.5% vs 13.2%; HR 1.37 (95% CI 0.96 to 1.95), P=0.08). However, the risk of stroke or death within 30 days was higher in the PTAS group (10.5% vs 4.2%; HR 2.62 (95% CI 1.49 to 4.61), P<0.001). Patients of white ethnicity (HR 1.97, 95% CI 1.17 to 3.31) and those with hyperlipidemia (HR 2.04, 95% CI 1.27 to 3.26) or a transient ischemic attack (TIA) (HR 2.19, 95% CI 1.08 to 4.45) were at higher risk for PTAS. Conclusions PTAS poses an increased risk of short-term stroke/death and therefore is not advised as primary treatment for symptomatic ICAS. A balance exists between stroke risks and revascularization benefits. For patients with asymptomatic ICAS of white ethnicity and those with hyperlipidemia or a history of TIA, a thorough assessment is warranted before considering PTAS. Trial registration ClinicalTrials.gov Identifier: NCT00576693 , NCT01763320 .
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈秋发布了新的文献求助10
1秒前
2秒前
2秒前
NEKO完成签到,获得积分10
3秒前
可可完成签到 ,获得积分10
3秒前
灵寒发布了新的文献求助10
5秒前
5秒前
6秒前
6秒前
7秒前
小馒头发布了新的文献求助10
8秒前
8秒前
9秒前
陈海伦完成签到 ,获得积分10
11秒前
科目三应助肉肉采纳,获得30
11秒前
12秒前
CZC完成签到,获得积分10
12秒前
秋秋完成签到,获得积分10
13秒前
EasonChan完成签到,获得积分10
14秒前
小邢一定行完成签到,获得积分10
14秒前
Zhukic完成签到,获得积分10
15秒前
影子发布了新的文献求助10
15秒前
16秒前
资明轩完成签到,获得积分10
17秒前
wangmeiqiong发布了新的文献求助10
18秒前
Hello应助玖玖柒idol采纳,获得10
18秒前
平淡的天宇应助左丘幼旋1采纳,获得10
23秒前
玥越发布了新的文献求助10
23秒前
jun完成签到,获得积分10
25秒前
25秒前
带线一去不回完成签到,获得积分10
26秒前
无花果应助垃圾智造者采纳,获得10
27秒前
张光光发布了新的文献求助10
28秒前
Able应助Steven采纳,获得10
28秒前
30秒前
耿教授发布了新的文献求助10
30秒前
小二郎应助博修采纳,获得10
31秒前
35秒前
愈疏发布了新的文献求助10
35秒前
wanci应助stinkyfish采纳,获得10
36秒前
高分求助中
Ophthalmic Equipment Market by Devices(surgical: vitreorentinal,IOLs,OVDs,contact lens,RGP lens,backflush,diagnostic&monitoring:OCT,actorefractor,keratometer,tonometer,ophthalmoscpe,OVD), End User,Buying Criteria-Global Forecast to2029 2000
A new approach to the extrapolation of accelerated life test data 1000
Cognitive Neuroscience: The Biology of the Mind 1000
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
A Preliminary Study on Correlation Between Independent Components of Facial Thermal Images and Subjective Assessment of Chronic Stress 500
Technical Brochure TB 814: LPIT applications in HV gas insulated switchgear 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3962822
求助须知:如何正确求助?哪些是违规求助? 3508736
关于积分的说明 11142697
捐赠科研通 3241520
什么是DOI,文献DOI怎么找? 1791604
邀请新用户注册赠送积分活动 872987
科研通“疑难数据库(出版商)”最低求助积分说明 803517